FDA Inspection 1278327 — Kaiser Permanente Center For Reproductive Health
The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on August 7, 2025 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 7, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Sacramento, CA (United States)